FDA Approves New Treatment For ALS

0

The FDA announced approval of #Relyvrio, developed by #Amylyx Pharmaceuticals, on Thursday. The oral medication works as a standalone therapy or when added to other treatments, according to the company, and it has been shown to slow disease progression.Details: https://www.cbsnews.com/boston/news/a…#cbsnewsmiami #news #health #medical #fda #als

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *